Sort
40,608 grants matching “prostate cancer”
PROSTATE CANCER IN AFRICAN-AMERICAN MEN: SERUM BIOMARKERS FOR EARLY DETECTION USING NANOPARTICLES
$337,439H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. · · FY2008 · Department of Defense
Molecular mechanisms initiating cell migrations in Caonorhabditis elegans
$337,428Martha C. Soto · Rbhs-Robert Wood Johnson Medical School · R01 · FY2020 · GM
Cellular Mechanisms of Bone Quality in Metastatic Breast Cancer
$337,410Gregory R Mundy · Vanderbilt University · P50 · FY2009 · CA
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE
$337,387Stanford University · R01 · FY2004 · DK
Molecular Probes Shed Light on Magnesium Homeostasis
$337,385Daniela Buccella · New York University · R01 · FY2019 · CA
Mechanisms of Radioresistance and Cell Cycle Progression
$337,379Howard B Lieberman · Columbia University Health Sciences · R01 · FY2014 · CA
Nuclear Neuropilin2: a novel molecular mediator for aggressive Prostate Cancer
$337,378Kaustubh Datta · Virginia Commonwealth University · R01 · FY2024 · CA
Southwest Oncology Group
$337,376Heinz Josef Lenz · University Of Southern California · U10 · FY2010 · CA
Southwest Oncology Group
$337,375Heinz Josef Lenz · University Of Southern California · U10 · FY2012 · CA
Southwest Oncology Group
$337,375Heinz Josef Lenz · University Of Southern California · U10 · FY2011 · CA
Core 1: Integrated Pathology and Radiology Core (iPRC)
$337,365Wei Huang · University Of Wisconsin-Madison · P50 · FY2025 · CA
PTEN TUMOR SUPPRESSOR AND CELL CYCLE REGULATION
$337,364Yale University · R01 · FY2002 · CA
Molecular probes for biomembrane recognition
$337,364Bradley D. Smith · University Of Notre Dame · R01 · FY2013 · GM
Activation of androgen biosynthesis and drug metabolism by cytochrome b5
$337,356Richard J Auchus · University Of Michigan At Ann Arbor · R01 · FY2016 · GM
UNRAVELING THE REGULATORY ROLE OF THE CYP27A1-27HC-KLF4 AXIS IN PROSTATE CANCER
$337,312Cedars-Sinai Medical Center · · FY2018 · Department of the Army
Reduced reactive oxygen species and oxidative phosphorylation in arsenic-induced cancer stem cells
$337,277Fei Chen · Wayne State University · R01 · FY2017 · ES
Reduced reactive oxygen species and oxidative phosphorylation in arsenic-induced cancer stem cells
$337,277Fei Chen · Wayne State University · R01 · FY2019 · ES
Discovery of Novel Selective Androgen Receptor Degraders (SARDs) for the Treatment of Spinobulbar Muscular Atrophy (SBMA) or Kennedyâs Disease
$337,272Ramesh Narayanan · University Of Tennessee Health Sci Ctr · R01 · FY2025 · NS
Integration of Vascular Genomics and Proteomics for Diagnosis and Therapy of Canc
$337,223Renata Pasqualini · University Of Tx Md Anderson Can Ctr · R33 · FY2008 · CA
Southwest Oncology Group
$337,210Heinz Josef Lenz · University Of Southern California · U10 · FY2013 · CA
Biostatistics
$337,199Mireya Diaz-Insua · Case Western Reserve University · P30 · FY2025 · CA
Core B: Liver Metastasis Resource Core (LMRC)
$337,190Edwin Melencio Posadas · Cedars-Sinai Medical Center · P01 · FY2023 · CA
Androgen-Independent Prostate Cancer: Mechanisms &Treat
$337,187Stanford University · R01 · FY2002 · CA
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression
$337,130Lorelei Mucci · Brigham And Women'S Hospital · R01 · FY2012 · CA
Cannabinoid CB2 Agonists for Treatment of Breast Cancer Induced Bone Pain
$337,106Todd W Vanderah · University Of Arizona · R01 · FY2018 · CA